ProShares UltraShort Health Care
3 hedge funds and large institutions have $276K invested in ProShares UltraShort Health Care in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
79% more call options, than puts
Call options by funds: $32.1M | Put options by funds: $18M
23.95% more ownership
Funds ownership: 2.9% → 26.85% (+24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$200K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$27.7K |
| 3 |
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$2.2K |
Top Sellers
RXD Hedge Fund Activity: Q4 2018 in Review
3 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q4 2018, worth a combined $276K — up 1,004% from $25K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RXD positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $200K.
- 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q4 2018, up from 1 in Q3 2018.
- Funds reported $276K of ProShares UltraShort Health Care stock for Q4 2018, up 1,004% quarter-over-quarter.
- 2 funds opened new ProShares UltraShort Health Care positions in Q4 2018 and 0 closed out, a net change of +2 holders.
- The largest ProShares UltraShort Health Care buyer in Q4 2018 was Envestnet Asset Management, an estimated $200K added.
Based on aggregated 13F filings for Q4 2018.